Literature DB >> 16913188

Age related changes in Fas (CD95) and Fas ligand gene expression and cytokine profiles in healthy Indians.

Meenakshi Sawhney1, Mary Mathew, Mani T Valarmathi, Satya N Das.   

Abstract

Ageing in human and animal models show changes in many aspects of protective immunity, particularly lymphopoenia and progressive decline in immune functions leading to increased frequency of infection and neoplasia. However, the exact mechanism of these defects is still unclear. In this study, elderly subjects showed a decline in CD3+ and CD4+ T-cell subsets as well as serum IL-2 levels. Serum IL-6 was significantly raised while expression of its signaling receptor gp130 was significantly impaired in elderly as compared to the younger ones. Additionally, all the elderly individuals showed constitutive expression of Fas and FasL mRNA; however, none of the younger individuals expressed mRNA transcripts constitutively although induced expression was seen in both the groups. Similarly, frequency of Fas and FasL expressing CD4+ and CD8+ T-cell subsets were significantly (p < 0.001) higher in elderly subjects as compared to the younger ones. Elderly individuals also showed a significantly (p < 0.001) higher frequency of activation induced cell death (AICD). Since interaction of Fas with its cognate ligand (FasL) activates death inducing caspases leading to apoptosis, and gp130 induces anti-apoptotic signal through STAT-3 pathway, these results suggest that the decline in protective immune functions in aged individuals may be related to Fas and FasL mediated apoptosis of peripheral T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913188

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  7 in total

1.  Accelerated apoptosis contributes to aging-related hyperinflammation in endotoxemia.

Authors:  Mian Zhou; Rongqian Wu; Weifeng Dong; Jennifer Leong; Ping Wang
Journal:  Int J Mol Med       Date:  2010-06       Impact factor: 4.101

2.  A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Authors:  Ming-Hsien Chien; Wei-Min Chang; Wei-Jiunn Lee; Yu-Chan Chang; Tsung-Ching Lai; Derek V Chan; Rahul Sharma; Yuan-Feng Lin; Michael Hsiao
Journal:  Mol Cancer Ther       Date:  2017-03-14       Impact factor: 6.261

3.  Patient demographics and disease variables correlate with distinct cytokine patterns in mitogen-stimulated peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Sukhbir Singh Uppal; Raj Raghupathy; Sawsan J Hayat; Rafiqul Islam Chowdhury; Mini Abraham; Parvez Rawoot
Journal:  Rheumatol Int       Date:  2007-11-29       Impact factor: 2.631

4.  Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

5.  Immunosenescence Study of T Cells: A Systematic Review.

Authors:  Ivon Johanna Rodriguez; Nicolás Lalinde Ruiz; Manuela Llano León; Laura Martínez Enríquez; María Del Pilar Montilla Velásquez; Juan Pablo Ortiz Aguirre; Oscar Mauricio Rodríguez Bohórquez; Esteban Alejandro Velandia Vargas; Edgar Debray Hernández; Carlos Alberto Parra López
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

6.  Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels.

Authors:  Anke Heigele; Simone Joas; Kerstin Regensburger; Frank Kirchhoff
Journal:  Retrovirology       Date:  2015-10-09       Impact factor: 4.602

7.  Sphingosine kinase‑1 mediates endotoxemia‑induced hyperinflammation in aged animals.

Authors:  Maria Lufrano; Asha Jacob; Mian Zhou; Ping Wang
Journal:  Mol Med Rep       Date:  2013-06-28       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.